Scan beyond Argan and see how options-driven moves compare with other contractors and infrastructure plays by reviewing our hand picked 30 resilient stocks with low risk scores.
For a shareholder in Argan, the core belief is that the engineering and construction backlog in power and infrastructure continues to support future projects, while the debt free balance sheet and sizeable cash and investments of about US$1.03b help absorb timing bumps. According to MarkoVT, an investor in the Simply Wall St Community, backlog replenishment is the key operational swing factor as existing work rolls off.
The recent spike in implied volatility around the December 2026 put options mostly highlights uncertainty on the timing or size of that next wave of awards, rather than changing the core story. The biggest near term risk still looks like delays in new project notices to proceed, given the backlog already moved from US$2.93b in January to US$2.52b by July as completions outpaced additions.
There have been no fresh company announcements listed alongside this options activity, so the most relevant reference point remains the earlier commentary on backlog and cash. Management indicated that future performance would lean heavily on signing several new projects over roughly a 7 to 15 month window, with those awards driving revenue visibility for Argan’s power heavy portfolio.
MarkoVT points out that previous guidance suggested the business could significantly exceed fiscal 2026 results, supported by strong cash and investments and no debt. However, this view depends on securing contracts with a relatively concentrated set of counterparties. That same concentration, combined with higher risk funding sources such as external borrowing rather than customer deposits, leaves execution on new awards and project mobilization as the central operational catalyst that options traders appear to be focused on.
On MarkoVT’s numbers, that US$266.82 fair value for Argan flows from revenue expanding about 19.2% a year and future profit margins at roughly 13.9%. Together, these figures feed into a forward P/E range that supports the lower end of the narrative’s estimated worth.
Uncover why Argan's fair value suggests a 12% potential downside to its current price, a premium that may not be sustainable.
For Argan, the lowest analysts lean hard into margin risk rather than backlog timing. They were already modeling revenue growth of about 13.3% a year and earnings of roughly US$219.8 million by 2029, yet still saw limited room for error. With options now flashing stress, those pre news forecasts may be challenged in either direction.
Explore 4 other Argan fair value estimates, including one that suggests as much as 27% downside from the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider forming your own view.
Once you have a view on Argan, it can help to widen the lens and see how other businesses stack up on quality, value, and income potential using the Simply Wall St Screener.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com